In trials, GSK’s vaccine significantly reduced ... identified a protein in RSV a decade ago that looked like a promising antigen for vaccine development. Both Arexvy and Abrysvo target this ...

GSK's vaccine has just hit the mark in a phase ... all awarded by the European Patent Office and covering recombinant RSV antigens and compositions and methods for making them.

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning about the risk of developing Guillain-Barré syndrome (GBS), a rare ...

and the clinical effectiveness of palivizumab and motavizumab validate RSV F protein as an attractive vaccine antigen. These epidemiological and clinical data combined with recent advances in RSV ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

The case is the latest filed by GSK against Pfizer over technology used in its vaccines. Last year, GSK sued Pfizer, alleging that Pfizer’s RSV vaccine Abrysvo infringed upon GSK’s patents for ...

U.S. sales of RSV vaccines have declined after regulators narrowed the age group eligible for the shots and determined they would be a one-time vaccination for now. For Pfizer and GSK, RSV ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Jan 7 (Reuters) - GSK (GSK.L), opens new tab and Pfizer's (PFE.N), opens new tab respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare ...

GSK’s marketed vaccines target infectious diseases at every stage of life, protecting people from meningitis, shingles, respiratory syncytial virus (RSV), flu, polio and many more. Every day ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration said on ...